The Editorial Team of Kidney International would like to reassure our readership that we will continue to bring you high quality information throughout the COVID-19 pandemic to help all of us deal with the crisis and provide high quality care to our patients. We have a mechanism in place to rapidly review and arrive at publication decisions for papers on the kidney implications of COVID-19, and release these papers in an open access format within one week after acceptance. We believe the best way nephrologists can contribute to the fight against this disease is by arming ourselves with the best and most up-to-date data possible.

The Editors of Kidney International would also like to thank all of our Reviewers for their outstanding work in guiding the publication of high impact papers. We understand that for most of us now many of our academic activities have been curtailed as we focus our efforts on combating the virus. We apologize to our Authors for any delays encountered in the reviewing process for non-COVID-19-related articles. Normal turnaround time for Kidney International averages 14 days for all original manuscripts, and we will make every effort to maintain a short review process during this time of stress.

During the first quarter of 2020 the number of submitted manuscripts to Kidney International has increased by 15% and we are grateful to the authors for choosing to publish with us despite the pandemic. We are very much aware of the huge professional and personal difficulties Authors are facing, including the shut down of laboratories and the virtual stand-still of most clinical trials, and we will take these difficulties into account during the reviewing process.

Despite all of these challenges, The Editorial Team remains dedicated to the mission of Kidney International and we are proud to serve the kidney community and contribute, together with the International Society of Nephrology, to global kidney health.  We are especially interested in well-designed papers on COVID-19 that provide impactful information on mechanisms, treatment and management of patients with kidney disease and COVID19 from diverse backgrounds. We would like to emphasize that those manuscripts will be subject to the same standards as all original articles submitted to KI. We are happy to hear from our readership and will appreciate any suggestions of how we can help you manage during this crisis.

Novel coronavirus disease (COVID-19) is a newly discovered contagious disease caused by SARS-CoV-2 virus, primarily manifesting as an acute respiratory illness with interstitial and alveolar pneumonia, but can affect multiple organs such as kidney, heart, digestive tract, blood and nervous system. The rapidly spreading outbreak which first emerged in Wuhan, Hubei Province in China in December 2019 has raised concerns about a global pandemic.

Read More

English Version Spanish Version

As part of its vision to ensure equitable access to kidney health globally, the International Society of Nephrology (ISN) is proud to launch the Emerging Leaders Program (ELP). With the aim of building a global talent pool of future leaders, the ELP welcomes ISN members interested in shaping the direction of kidney health through professional development and improved understanding of health policy and implementation to ensure health promotion and access to prevention, control and management of kidney diseases.

The Program will provide participants worldwide with the opportunity to work closely with international experts in order to develop leadership and advanced capabilities in:

  • implementation science and research;
  • developing and implementing evidence-informed policy;
  • evaluation, development and management of health systems;
  • principles of entrepreneurship, advocacy and communications;
  • influencing stakeholders including policymakers, funders, implementers and media.

To participants, the ELP offers (1) becoming part of a global network consisting of experts who positively impact the kidney health agenda around the world through collaboration as well as high quality and multidisciplinary research in discovery and implementation science; (2) empowerment to find innovative ways to let their voices be heard so they can act as agents of change at the local and international level and (3) access to continuous professional development to acquire the necessary resources, skills and knowledge to take on leadership roles locally and globally

Successful candidates will be matched with a mentor drawn from the ISN leadership to help them map out their journey and reach their career goals.

Eligibility Criteria:

  • Early career academic (MD and/or PhD) as defined by being at the Fellow/Instructor/Assistant Professor level or equivalent for other countries.
  • The call is open to non-academics at comparable career levels who are interested in improving the global kidney health agenda.
  • Talented and motivated early-career professional (less than 10 years out of residency or training)
  • Be able to demonstrate commitment to the improvement of global kidney health using a collaborative approach.
  • Be a member of ISN (Not a member? Join here)

Information Session and Applications
An information session will be scheduled to take place at the World Congress of Nephrology in Abu Dhabi (26-29 March 2020). The application session will open shortly after the Congress.

If you would like to attend the information session or ask questions about the program, please contact Marie-Pierre Smal at

A multidisciplinary group of researchers and clinicians met in October 2018 to identify evidence and address controversies in potassium management providing research priorities and guidance for evaluation and management of dyskalemias in the context of kidney diseases.

Celebrate World Kidney Day (WKD) by organizing an awareness event in your community: a sports event, a concert, a roundtable talk, a flash mob, or even a street fest.

If you need help organizing a World Kidney Day event, download the 2020 “events guide”. If you’ve already planned your event, please add it to the interactive worldwide map.

Follow World Kidney Day social media channels (@worldkidneyday, worldkidney_day, @worldkidneyday) to take part in a fun interactive activity next month celebrating 15 years of WKD (#gr8).

Tuesday, 21 January 2020 14:00

Simulation Certificate Course in Abu Dhabi

Given the steadily increasing demand for interventional nephrology in low and middle-income countries, the ISN, with generous support from Cleveland Clinic, will hold a simulation training session from 8 a.m. to 12.30 p.m. on Friday, March 27, 2020, in Abu Dhabi.

The course focuses on learning and practicing procedures, such as central venous catheter placement, kidney biopsies, and physical examination of vascular access under supervision. The aim is to offer supervised training to help students feel comfortable performing the procedures. This course is separate from the Interventional Nephrology pre-course taking place on Thursday 26 at WCN20.

As a component of this course in Abu Dhabi, ISN will shortly release an online didactic module designed for general nephrologists, nephrology trainees, advanced practitioners, nephrology nurses, and technicians. It will provide an overview of vascular access biology, process of care, identification of complications, and fundamentals of quality improvement goals. To receive the “Mastery in Simulation Training” certificate, this online module must be completed and a supervised simulation training must be passed prior to the hands-on training session in Abu Dhabi.

The registration fee for the course is $1,000. Cleveland Clinic has generously agreed to sponsor the course fee for 15 trainees from low to middle-income countries. The sponsored delegates will be recognized as Brenda and Tim Huval Interventional Nephrology Scholars.

The course has a maximum capacity of 30 people. If you would like to participate in the course, please complete the registration form and send to before March 3.

Supported by CCF

Registration Form

In honor of the late influential nephrologist and former Editor of Kidney International Detlef Schlöndorff, ISN has set up the Detlef Schlöndorff Fellowship Fund to support training for one Fellow per year.

The ISN congratulates Dr. Etienne Ntabanganyimana, from the Gihundwe Hospital in Rwanda, who has been selected as the first Detlef Schlöndorff Fellow by the ISN Fellowship Committee.

Dr. Ntabanganyimana will travel to India to spend 12 months training under the mentorship of Prof. Santosh Varughese at the Christian Medical College in Vellore. His training will focus on Interventional Nephrology.

The ISN wishes to thank Barbel Schlöndorff, wife of the late Detlef Schlöndorff, Patricia and Jeremiah Morrissey, and Pierre Ronco for their generous donations toward funding this fellowship.

Donations to the Detlef Schlöndorff Fellowship Fund can be made by PayPal. If you would like to make a donation by check or bank transfer, please contact Thomas Jacob, ISN Fellowship Program Coordinator, by email at

Tuesday, 21 January 2020 13:54

Access the latest ISN-ACT Global Trials

Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world.


  • Brace for it: an external support device may help fistulas to mature
  • Getting things straight when it comes to peritoneal dialysis catheters

See the latest trials here

In the second half of 2019, ISN led two meetings in Colombia providing education on pediatric and adult kidney transplantation and patient accessibility to renal transplantation services.

The ISN-Transplant Society (TTS) Sister Transplant Center (STC) pair, Boston Children´s Hospital and ISN emerging center Fundación Valle del Líli in Cali, Colombia, held a meeting on the immunopathology of kidney transplantation from August 27-28, 2019, in Cali Colombia. This meeting was part of the ISN Continuing Medical Education Program (CME). The guest speaker, Dr. Andres Jaramillo, Director of the Histocompatibility Laboratory and Associate Professor of Laboratory Medicine and Pathology at the Mayo Clinic in Arizona, gave several talks over the course of the two-day conference, which included a workshop and laboratory in immunopathology of kidney transplantation.

The ISN Sister Renal Center (SRC) trio, ISN mentoring center Boston Children’s Hospital, ISN supporting center Fundacion Valle del Líli, and and ISN emerging center Hospital Susana López de Valencia in Popayàn, in collaboration with the Colombian Association of Nephrology (ASOCOLNEF) and the Colombian Pediatric Nephrology Association (ACONEPE) held a second meeting on acute and chronic kidney disease, “Renal health for everybody, everywhere”, from October 25-26, 2019, in Popayàn, Colombia. Dr. Francisco Flores, associate professor and consultant at Cincinnati Children’s Hospital, USA, was an invited speaker at the event.

According to Dr. Restrepo, the region faces several challenges: the mortality rate of acute kidney disease is high and more training in AKI detection and treatment is needed; there are difficulties communicating with the large aboriginal population with renal diseases in the Southwest region, and Cali is a long distance drive for many, with few direct planes. Popayàn has almost 650 patients in renal replacement therapy (RRT), and Pasto has 900 patients in RRT waiting for kidney transplantation (KTx).

Following these meetings, Popayan received the support necessary to start academic meetings and workshops to enhance RRT and stimulate interest for these programs among the medical population.

Drs. Andrés Jaramillo and Jaume Martorell from the Hospital Clinic, Barcelona, and Edgar Milford from Brigham and Women’s Hospital, Boston, support the Fundación Valle del Líli’s kidney immunopathology and tissue typing laboratory development. Plans are currently being made to set up two additional transplant centers in Popayan and Pasto. The ISN SRC and ISN-TTS STC Programs have supported and trained nurses, laboratory professionals, as well as adult and pediatric nephrologists toward launching the transplant program in Popayàn.

To celebrate ISN’s 60th anniversary throughout 2020, Kidney International’s “Milestones in Nephrology” series launches with a review of the development in understanding of the pathophysiology of the glomerulus, highlighting several original articles published in KI:

The glomerular signature in patients with hematuria (Kenneth F. Fairley and Douglas F. Birch, 1982);

The permselectivity of the glomerular capillary wall (Ramsay L.S. Chang, William M. Deen, Channing R. Robertson, and Barry M. Brenner, 1975);

T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations (Bolton W.K., Innes D.J. Jr., Sturgill B.C., Kaiser D.L., 1987);

Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis (Yoshida Y., Fogo A., Ichikawa I., 1989); and

Genetic studies into inherited and sporadic hemolytic uremic syndrome (Warwicker P., Goodship T.H.J., Donne R.L., et al., 1998).

These articles, despite sometimes triggering controversy, opened the way for improved patient care, innovative therapeutic intervention, and genetic screening.

These groundbreaking papers from KI, shared monthly, will be discussed by an editor from KI and put into perspective of the most recent advances in the field.

Page 1 of 5

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact